Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

8.490
+0.1601.92%
Volume:110.99M
Turnover:947.98M
Market Cap:97.82B
PE:23.03
High:8.720
Open:8.460
Low:8.300
Close:8.330
52wk High:11.454
52wk Low:4.463
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:1.36
T/O Rate:0.96%
Dividend:0.24
Dividend Rate:2.82%
EPS(LYR):0.369
ROE:10.83%
ROA:5.65%
PB:2.60
PE(LYR):23.03
PS:3.29

Loading ...

LIVE MARKETS-Europe before the bell: positive earnings sweeten the mood

Reuters
·
Jan 30

UK Stocks-Factors to watch on January 30

Reuters
·
Jan 30

Stock Track | CSPC Pharma Plummets 12.82% Intraday Following AstraZeneca Collaboration Announcement

Stock Track
·
Jan 30

China's CSPC Pharmaceutical inks deal with AstraZeneca for weight loss therapy

Reuters
·
Jan 30

CSPC PHARMA (01093) Signs Strategic Collaboration and Licensing Agreement with AstraZeneca for Innovative Long-Acting Peptide Drug Development

Stock News
·
Jan 30

BRIEF-CSPC Pharmaceutical Group Enters Strategic Collaboration And License Agreement With Astrazeneca

Reuters
·
Jan 30

CSPC Pharmaceutical Group Strikes $1.2 Billion Global Peptide Drug Deal with AstraZeneca

Reuters
·
Jan 30

Voluntary Announcement - Entering Into a Strategic Collaboration and License Agreement With AstraZeneca for the Development of Innovative Long-Acting Peptide Medicines

THOMSON REUTERS
·
Jan 30

CSPC PHARMA (01093): SYS6055 Injection Receives Clinical Trial Approval in China

Stock News
·
Jan 29

CSPC Pharmaceutical Group Wins China Approval for SYS6055 Injection Clinical Trials

Reuters
·
Jan 29

CSPC Pharmaceutical - Approval From National Medical Products Administration of China

THOMSON REUTERS
·
Jan 29

CSPC Pharmaceutical - Sys6055 Injection Approved for Clinical Trials in China

THOMSON REUTERS
·
Jan 29

CSPC Pharmaceutical Group Stock Advances 1.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Jan 29

CSPC Pharmaceutical Group Stock Rallies 6.1% in Hong Kong, Outperforms Competitors

Dow Jones
·
Jan 28

CSPC Pharma (01093) Surges Over 5% as Clinical Study Results of Co-Developed Anituzumab Published in Annals of Oncology

Stock News
·
Jan 28

Zhytong Hong Kong Stock Analysis | UK Prime Minister's China Visit Boosts Market Sentiment, Price Hike Concepts Strengthen Collectively

Stock News
·
Jan 27

CSPC Pharmaceutical Grants Shares to Employees Under Award Scheme

Reuters
·
Jan 26

CSPC PHARMA Grants 46.4625 Million Restricted Shares in Total

Deep News
·
Jan 26

Assessing CSPC Pharmaceutical Group (SEHK:1093) Valuation After Dual Hypertension And Diabetes Pipeline Updates

Simply Wall St.
·
Jan 24

CSPC PHARMA (01093) Grants a Total of 46.4625 Million Award Shares

Stock News
·
Jan 23